William Hagstrom, CEO of San Francisco-based Crescendo Bioscience, was one of the presenters at the recent 2014 BioSummit in Oklahoma City where he described how he built both Crescendo and Oklahoma City’s Urocor in the 1990s. Crescendo was recently acquired by Myriad Genetics in a $270 million transaction.
At the request of several people who attended the BioSummit, Hagstrom agreed to share most of his presentation with us so we could make it available to a wider audience. Click here to see the presentation.
